1. Home
  2. MSBI vs SGP Comparison

MSBI vs SGP Comparison

Compare MSBI & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Midland States Bancorp Inc.

MSBI

Midland States Bancorp Inc.

HOLD

Current Price

$33.54

Market Cap

668.5M

Sector

Finance

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$24.88

Market Cap

650.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MSBI
SGP
Founded
1881
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.5M
650.9M
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
MSBI
SGP
Price
$33.54
$24.88
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$24.33
$45.00
AVG Volume (30 Days)
175.4K
87.7K
Earning Date
04-23-2026
05-15-2026
Dividend Yield
5.00%
N/A
EPS Growth
N/A
N/A
EPS
1.56
N/A
Revenue
N/A
N/A
Revenue This Year
$18.41
N/A
Revenue Next Year
$2.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.24
$17.06
52 Week High
$35.10
$30.56

Technical Indicators

Market Signals
Indicator
MSBI
SGP
Relative Strength Index (RSI) 59.89 67.27
Support Level $29.78 $20.95
Resistance Level N/A $25.83
Average True Range (ATR) 0.93 1.35
MACD -0.07 0.35
Stochastic Oscillator 68.35 82.64

Price Performance

Historical Comparison
MSBI
SGP

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: